remifentanil fresenius kabi 5 mg inj./inf. opl. (pdr., conc.) i.v. flac.
fresenius kabi sa-nv - remifentanilhydrochloride 5,5 mg - eq. remifentanil 5 mg - poeder voor concentraat voor oplossing voor injectie/infusie - 5 mg - remifentanilhydrochloride 5.5 mg - remifentanil
remifentanil hydrochloride injection, powder, lyophilized, for solution remifentanil hydrochloride- remifentanil hydrochloride
fresenius kabi usa, llc - remifentanil hydrochloride (unii: 5v444h5wic) (remifentanil - unii:p10582jyyk) - remifentanil 1 mg in 1 ml - remifentanil hydrochloride (hcl) for injection is indicated for intravenous (iv) administration: - as an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures. - for continuation as an analgesic into the immediate postoperative period in adult patients under the direct supervision of an anesthesia practitioner in a postoperative anesthesia care unit or intensive care setting. - as an analgesic component of monitored anesthesia care in adult patients. remifentanil hcl is contraindicated: - for epidural or intrathecal administration due to the presence of glycine in the formulation [see nonclinical toxicology (13)] . - in patients with hypersensitivity to remifentanil (e.g., anaphylaxis) [see adverse reactions (6.2)] . risk summary prolonged use of opioid analgesics during pregnancy may cause neonatal opioid withdrawal syndrome. available data with remifentanil hydrochloride in pregnant women are insufficient to
sufentanil eurocept 5 microgram/ml, oplossing voor injectie
eurocept international b.v. trapgans 5 1244 rl ankeveen - sufentanilcitraat samenstelling overeenkomend met ; ; sufentanil 5 µg/ml - oplossing voor injectie - citroenzuur 1-water (e 330) ; natriumchloride ; natriumhydroxide (e 524) ; stikstof (head space) (e 941) ; water voor injectie ; zoutzuur (e 507), - sufentanil
sufentanil eurocept 50 microgram/ml, oplossing voor injectie
eurocept international b.v. trapgans 5 1244 rl ankeveen - sufentanilcitraat samenstelling overeenkomend met ; ; sufentanil 50 µg/ml - oplossing voor injectie - citroenzuur 1-water (e 330) ; natriumchloride ; natriumhydroxide (e 524) ; stikstof (head space) (e 941) ; water voor injectie ; zoutzuur (e 507), - sufentanil
sufentanil narcomed, 50 microgram/ml oplossing voor injectie
eurocept international b.v. trapgans 5 1244 rl ankeveen - sufentanilcitraat samenstelling overeenkomend met ; ; sufentanil 0,05 mg/ml - oplossing voor injectie - citroenzuur 1-water (e 330) ; natriumchloride ; stikstof (head space) (e 941) ; water, gezuiverd, - sufentanil
alfentanil gh injection alfentanil (as hydrochloride) 1 mg/2 ml injection ampoule
generic health pty ltd - alfentanil hydrochloride, quantity: 1.0876 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - alfentanil gh injection is indicated for intravenous use by specialist anaesthetists and their trainees as:,? an analgesic supplement given by incremental intravenous boluses or continuous infusion; and,? an anaesthetic induction agent where in patients undergoing in-patient surgery, when endotracheal intubation and controlled ventilation are to be used.,because of its rapid onset and short duration of action, intravenous alfentanil gh injection is particularly suited as a narcotic analgesic for short procedures and outpatients, provided that the patients are maintained under appropriate post-operative surveillance. however, intravenous alfentanil gh injection is also useful as an analgesic supplement for procedures of medium to long duration, since periods of very painful stimuli can be easily overcome by administration of small increments of alfentanil gh injection or by adapting the infusion rate.
alfentanil gh injection alfentanil (as hydrochloride) 5 mg/10 ml injection ampoule
generic health pty ltd - alfentanil hydrochloride, quantity: 5.438 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - alfentanil gh injection is indicated for intravenous use by specialist anaesthetists and their trainees as:,? an analgesic supplement given by incremental intravenous boluses or continuous infusion; and,? an anaesthetic induction agent where in patients undergoing in-patient surgery, when endotracheal intubation and controlled ventilation are to be used.,because of its rapid onset and short duration of action, intravenous alfentanil gh injection is particularly suited as a narcotic analgesic for short procedures and outpatients, provided that the patients are maintained under appropriate post-operative surveillance. however, intravenous alfentanil gh injection is also useful as an analgesic supplement for procedures of medium to long duration, since periods of very painful stimuli can be easily overcome by administration of small increments of alfentanil gh injection or by adapting the infusion rate.
remifentanil teva 1 mg inj./inf. opl. (pdr., conc.) i.v. flac.
teva pharma belgium sa-nv - remifentanilhydrochloride 1,1 mg - eq. remifentanil 1 mg - poeder voor concentraat voor oplossing voor injectie/infusie - 1 mg - remifentanilhydrochloride 1.1 mg - remifentanil
remifentanil teva 2 mg inj./inf. opl. (pdr., conc.) i.v. flac.
teva pharma belgium sa-nv - remifentanilhydrochloride 2,2 mg - eq. remifentanil 2 mg - poeder voor concentraat voor oplossing voor injectie/infusie - 2 mg - remifentanilhydrochloride 2.2 mg - remifentanil
remifentanil teva 5 mg inj./inf. opl. (pdr., conc.) i.v. flac.
teva pharma belgium sa-nv - remifentanilhydrochloride 5,5 mg - eq. remifentanil 5 mg - poeder voor concentraat voor oplossing voor injectie/infusie - 5 mg - remifentanilhydrochloride 5.5 mg - remifentanil